You are not logged in. Login or Signup
Home » links » Link 323675 | Random (Thread)

This is a normal post Right...
Firstly, let me just say that I am in favour of hESC research/treatment etc. Just so you know that this is from a pedantry, rather than a morality standpoint.

Firstly, using hESC's is more risky since there is some chance of rejection (if we had a program of storing umbilical stem cells at birth this could be avoided (provided they work of course)), wheras using the patients own stem cells avoids this (especially since there is no other biological matter introduced during the procedure).

On the risk from the operations, the patient is already losing their sight for one, and any damage done in the second procedure will be repaired along with it (i presume, since it is replacing the removed damaged cells, it should also be able to replace removed healthy ones). The second procedure also carries a low risk of infection, since the cornea is not completely breached. As for the initial biopsy, i don't know enough to comment.

The other advantage to using the stem cells (at this point I am speculating a bit) is that the ones taken from the eye may already be somewhat specialised, and therefore more likely to assume the correct forms on the contact lens than embryonic stem cells (like I say, that last part is entirely speculation, I do physics, biology is too squishy for me)
(, Wed 3 Jun 2009, 23:23, Reply)
This is a normal post Hi -
I genuinely can't comment on the rejection point - it had occurred to me, but it's not a point that's raised often in respect of hESC, so my general impression is that the risk isn't so huge. Don't know. If any medical types here can settle it either way, that'd be a good thing.

As for the other stuff: I disagree. The danger with using the patient's own cells is not the risk of blindness - it's the more general risk associated with any operation: anaesthetic risk mainly, but a whole host of other stuff (including, if you insist, the mere worry about having a second operation). With embryonic cells, all that is avoided, so to subject the patient to those risks seems arbitrary, unwarranted and therefore not morally straightforward. Wouldn't there be a greater chance of failure, too, if you're using cells from the very organ you're trying to cure? This would also speak to your specialisation point. Finally, I don't think that specialisation ought to be all that big a worry: for one thing, it doesn't take long for stem cells to specialise; for another, there might well be something to be said for having them unspecialised to begin with to allow a bit of adaptive flexibility when the graft is made.

Nope. I'm not a biologist either. I have a disappointing GCSE in physics, and that's as far as my scientific education goes.
(, Thu 4 Jun 2009, 8:40, Reply)